Breast cancer: The main area of morbidity is breast tissue, which is one of the most common malignant tumours in women, and although men may also have breast cancer, the incidence is extremely low. The age of morbidity is more widely distributed, although it is relatively high in the 45-55 age group. – Lung cancer: in the lung. Men have a higher incidence than women, and morbidity is closely related to smoking, air pollution, occupational exposure (e.g. asbestos). Most of the cases occur between 50 and 70 years of age, and the number of young patients has increased in recent years. – Stomach cancer: in the stomach. In some areas with high levels of eating habits, such as long-term high-salt, pickled food. Men have more diseases than women, with a peak age of 50 to 70 years, related to the infection of the fungus, genetic factors, etc. – Clostridic cancer: Illness in the colon or rectal. The rate of morbidity is similar for both sexes and the risk of morbidity increases with age, especially for those over 50. Poor dietary structure (e.g., high fat, high protein, low-fibre diet) and chronic intestinal inflammation are the main contributing factors. Symptoms – Breast cancer: common symptoms are breast swelling, breast spills, breast skin changes (e.g., “dimple” “Orange” changes), nipple or euphemism abnormalities, and lymphoma swollenness in the armpit. – Lung cancer: There may be no visible symptoms at an early stage, with symptoms such as cough (especially irritating dry cough), crotch, chest pain, breathing difficulties, fever, etc. as the condition develops. – Stomach cancer: Early symptoms are not typical and may be limited to upper abdominal discomfort, reduced appetite, etc. During the period of progress, symptoms of increased upper abdominal pain, vomiting, black defecation, wasting, etc. – rectum cancer: early defecation habits may change (e.g. constipation or diarrhea alternation), constipated blood, etc. Late signs of intestinal infarction, abdominal swelling, anaemia, wasting etc. Diagnosis – Breast cancer: Common breast ultrasound (for young women and amplified mammograms), mammogram X-ray mammograms (sensitive to small calcium stoves, commonly used by women over 40 years of age), mammograms (MRI) for screening and assessment of the extent of the disease among high-risk groups, as well as a pathological biopsy. – Lung cancer: lung pathologies are detected through chest X-rays, CT scans, bronchoscopy allows direct observation of the inside of the bronchial trachea and a biopsy, and can also be diagnosed with perforated pulmonary pulmonary puncture. – Stomach cancer: The most important diagnostic method is gastroscopy, which directly detects intestinal pathologies and takes active examinations. An upper digestive feeding examination can also assist in the detection of a disease, but with a slight deterioration in accuracy. – Enteric cancer: colonoscopy is a key means of diagnosis, allowing for the observation of the intestinal condition and the recovery of a biopsy. Pee-divination tests can be used as an early screening method and CT colon imaging can be used to assist diagnosis. Treatment – Breast cancer: The main methods of treatment are surgery (e.g. breast cancer improvement root therapy, breast milk surgery), chemotherapy, leaching, endocrine treatment (for estrogen-positive patients) and targeted treatment (for Her-2 positive patients). – Lung cancer: treatments include surgery, chemotherapy, free treatment, target-oriented treatment and immunisation according to the type of lung cancer (non-small cell lung cancer and small cell lung cancer) and staged. Small-cell lung cancer is more sensitive to chemotherapy and treatment. – Stomach cancer: Priority surgical treatment, using a combination of chemotherapy, treatment, and target-oriented treatment for patients who cannot. Stomach cancer surgery includes root and palliative surgery. – Constituent cancer: early surgery is the main method, followed by chemotherapy, depending on the condition. Comprehensive treatments such as chemotherapy, target treatment and immunotherapy are also used for late-stage patients. Post-pregnancy – Breast cancer: If detected early and treated, the survival rate is high at around 90 per cent over five years. Late breast cancer is expected to be relatively poor, with long-range transfers such as bone transfer, lung transfer, etc. – Lung cancer: the overall forecast is poor, especially small-cell lung cancer, with a low survival rate of five years. Early detection and treatment of non-small-cell lung cancer can increase over five years. – Stomach cancer: Early stomach cancer is expected to be better, with a survival rate of more than 90 per cent over five years; later stomach cancer has a low survival rate of about 20 per cent for five years. – Clothectal cancer: The survival rate of early colon cancer can reach 90 per cent over five years, but later patients have a poor forecast, and the survival rate has decreased following long-term transfers such as liver transfer.
Breast cancer
